Vertex Pharmaceuticals Inc
XMUN:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XMUN:VX1
|
US |
|
D
|
Denso Corp
SWB:DNO
|
JP |
|
Sumitomo Densetsu Co Ltd
TSE:1949
|
JP |
|
R
|
Ryanair Holdings PLC
XMUN:RY4C
|
IE |
|
Siemens AG
F:SIEB
|
DE |
|
C
|
Comcast Corp
XHAM:CTP2
|
US |
|
B
|
Bank of America Corp
XBER:NCB
|
US |
|
A
|
Agricultural Bank of China Ltd
XMUN:EK7
|
CN |
|
V
|
Verizon Communications Inc
DUS:BAC
|
US |
|
B
|
Baidu Inc
XMUN:B1CB
|
CN |
|
S
|
Synopsys Inc
XMUN:SYP
|
US |
|
A
|
Aristocrat Leisure Ltd
F:AC8
|
AU |
|
D
|
Discover Financial Services
XMUN:DC7
|
US |
|
A
|
Abb Ltd
BMV:ABBN
|
CH |
Wall St Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VX1 is 477.04 EUR with a low forecast of 283.49 EUR and a high forecast of 572.46 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
477.04
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 477.04 EUR with a low forecast of 283.49 EUR and a high forecast of 572.46 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 3 years is 17%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 3 years is 18%.
